Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
32.4%
% of IHE's 38 holdings also in PPH
50.0%
% of PPH's 27 holdings also in IHE
Overlap by Weight
Sector Drift (IHE minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in IHE |
Weight in PPH |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 20.4% | 12.4% | 12.4% | |
JOHNSON & JOHNSON | 21.2% | 6.4% | 6.4% | |
BRISTOL-MYERS SQUIBB CO | 5.5% | 5.7% | 5.5% | |
ZOETIS INC | 4.5% | 4.7% | 4.5% | |
MERCK & CO. INC. | 4.2% | 5.0% | 4.2% |
Position Highlights (Non-Overlapping Exposures)
IHE Overweight Relative to PPH
JOHNSON & JOHNSON | 14.8% | |
ELI LILLY & CO | 8.0% | |
ROYALTY PHARMA PLC CLASS A | 4.0% | |
CATALENT INC | 3.5% | |
INTRA-CELLULAR THERAPIES INC | 3.4% | |
VIATRIS, INC. | 3.1% | |
CORCEPT THERAPEUTICS INC | 2.1% | |
JAZZ PHARMACEUTICALS PLC | 2.0% | |
ELANCO ANIMAL HEALTH, INC. | 1.9% | |
PRESTIGE BRANDS HOLDINGS INC | 1.7% |
IHE Underweight Relative to PPH
NOVO-NORDISK A/S-SPONS ADR | -8.1% | |
ABBVIE INC | -5.9% | |
MCKESSON CORP | -5.6% | |
AMERISOURCEBERGEN CORP | -4.9% | |
NOVARTIS AG-ADR | -4.7% | |
ASTRAZENECA PLC-SPONS ADR | -4.6% | |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -4.5% | |
SANOFI-AVENTIS-ADR | -4.0% | |
GLAXOSMITHKLINE PLC-SPON ADR | -3.9% | |
TEVA PHARMACEUTICAL-SP ADR | -3.6% |